文献
J-GLOBAL ID:202202243352596190
整理番号:22A0562378
2型糖尿病の臨床診療におけるGLP-1受容体作動薬とDPP-4阻害剤と腎臓および心血管転帰の比較【JST・京大機械翻訳】
GLP-1 receptor agonist versus DPP-4 inhibitor and kidney and cardiovascular outcomes in clinical practice in type-2 diabetes
著者 (8件):
Xu Yang
(Peking University Clinical Research Institute, Peking University First Hospital, Beijing, China)
,
Xu Yang
(Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden)
,
Fu Edouard L.
(Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden)
,
Fu Edouard L.
(Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands)
,
Clase Catherine M.
(Department of Medicine and Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada)
,
Mazhar Faizan
(Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden)
,
Jardine Meg J.
(Kidney Health Research, NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia)
,
Carrero Juan J.
(Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden)
資料名:
Kidney International
(Kidney International)
巻:
101
号:
2
ページ:
360-368
発行年:
2022年
JST資料番号:
E0559B
ISSN:
0085-2538
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)